US Patent Issued to Gwo Xi Stem Cell Applied Technology on June 9 for "High-expression type mesenchymal stem cells, culture method and use thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,902, issued on June 9, was assigned to Gwo Xi Stem Cell Applied Technology Co. Ltd. (Zhubei, Taiwan).

"High-expression type mesenchymal stem cells, culture method and use thereof" was invented by Wei Wu Li (Zhubei, Taiwan), Tzyy-Wen Chiou (Zhubei, Taiwan), Horng-Jyh Harn (Zhubei, Taiwan), Shinn-Zong Lin (Zhubei, Taiwan), Ming-Hsi Chuang (Zhubei, Taiwan), Po-Cheng Lin (Zhubei, Taiwan), Chia-Hsin Lee (Zhubei, Taiwan) and Mao-Hsuan Huang (Zhubei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a medicine for treating a neurodegenerative disease, which employs LEFTY2 (Left-Right Determination Factor 2) generated by co...